Internal Medicine, Pulmonary Disease · Sheboygan, WI
NPI
1013992643
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2414 Kohler Memorial Dr
Sheboygan, WI, 53081
Phone (920) 457-4461
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
986 services
Medicare patients, 2024
418
Average age 72
Drug cost, 2024
$492K
909 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip M Detrana was code 94010 (pulmonary function testing), 155 times for 103 patients. In total Philip M Detrana billed 986 services in 28 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Office | 155 | 103 | $15.54 | $2,409 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 144 | 46 | $0.03 | $4.92 |
| 95811 Sleep Study | Office | 114 | 104 | $80.26 | $9,149 |
| 99214 Office E&M - Established | Office | 108 | 106 | $84.96 | $9,176 |
| 99215 Office E&M - Established | Office | 80 | 67 | $128.58 | $10K |
| 95810 Sleep Study | Office | 77 | 77 | $76.49 | $5,890 |
| 94729 Pulmonary Function Testing | Office | 50 | 48 | $39.23 | $1,961 |
| 94060 Pulmonary Function Testing | Office | 47 | 46 | $26.87 | $1,263 |
| 94726 Pulmonary Function Testing | Office | 47 | 46 | $37.65 | $1,770 |
| 99291 Critical Care E&M | Facility | 37 | 19 | $155.23 | $5,744 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 24 | 24 | $28.33 | $680 |
| 94618 Pulmonary Function Testing | Office | 22 | 22 | $24.31 | $535 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 12 | $87.16 | $1,482 |
| 99204 Office E&M - New | Office | 11 | 11 | $105.10 | $1,156 |
By year: 2022 $54K for 764 services; 2023 $61K for 1,037 services; 2024 $56K for 986 services.
Medicare prescription drug claims, 2024
In 2024, the drug Philip M Detrana prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 184 prescriptions and refills. In total Philip M Detrana wrote 909 Medicare prescriptions that cost $492K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 184 | 243 | 31 | $151K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 132 | 155 | 52 | $3,522 |
| Montelukast Sodium Generic | 117 | 260 | 29 | $1,394 |
| Fluticasone Propionate Generic | 101 | 221 | 35 | $1,960 |
| Breo Ellipta Fluticasone/Vilanterol | 49 | 57 | 11 | $22K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 41 | 59 | 14 | $5,521 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 24 | 24 | Under 11 | $12K |
| Spiriva Handihaler Tiotropium Bromide | 23 | 37 | Under 11 | $17K |
| Zolpidem Tartrate Generic | 21 | 21 | 20 | $20.25 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 20 | 34 | Under 11 | $3,014 |
| Ventolin Hfa Albuterol Sulfate | 17 | 17 | Under 11 | $881 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 16 | 24 | Under 11 | $3,932 |
| Prednisone Generic | 16 | 17 | Under 11 | $190 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 12 | 21 | Under 11 | $12K |
| Aralast Np Alpha-1-Proteinase Inhibitor | 12 | 12 | Under 11 | $226K |
Brand drugs: 494 claims; generic drugs: 415 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Philip M Detrana were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.